Skip to Main Content

Paper Details

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.
Sci Adv
8
2023
AR, PCa, PCa cell models, PI-4,5-P, PI5P4K, PI5P4K isoform, Phosphatidylinositol, androgen, androgen receptor, cancer, mTORC1, mTORC1 complex, mouse, phosphatidylinositol, phosphatidylinositol-5-phosphate 4-kinases, prostate cancer
Author NameAffiliation
Julijana IvanisevicUniversity of Lausanne
Salvatore PiscuoglioUniversity of Basel
Lewis C CantleyMeyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Lewis C CantleyDana-Farber Cancer Institute, Harvard Medical School
Mark A RubinUniversity of Bern
Mark A RubinBern Center for Precision Medicine, University of Bern and Inselspital
Mark A RubinUniversity of Bern
Mark A RubinBern Center for Precision Medicine, University of Bern and Inselspital
  • 1 - 8

Datasets

Release 1.2